Center for Blood Research, Inc.

Roberto Rodolfo Kretschmer Schmid

The invention relates to an anti-inflammatory oligopeptide which can be obtained from the microorganismor synthesized by known methods. The oligopeptides are useful in treating inflammatory diseases when formulated in pharmaceutical compositions for administration to patients.

Monocyte locomotion inhibitory factor

The invention relates to an anti-inflammatory oligopeptides which contain the terminal pharmacophore Cys-Asn-Ser which is capable of inhibiting the NF-&#x3ba;&#x3b2; signaling pathway. The oligopeptides are useful in stimulating the in vivo production of IL-10, and for treating inflammatory diseases and scarring when formulated in pharmaceutical compositions for administration to patients.

Growing community of inventors

Pedregal, Mexico

Roberto Rodolfo Kretschmer Schmid